Satellite Banner
Technology Networks Header
Friday, September 19, 2014
Technology Networks
 
Register | Sign in
Home Page > Videos > Improvements in Molecular Diagnosis of Pathogens and Diseases
  Videos

Return

Improvements in Molecular Diagnosis of Pathogens and Diseases
SELECTBIO

Loop-mediated Isothermal Amplification (LAMP) belongs to a range of main current and new diagnostic techniques for early-stage detection of pathogens such as viruses, bacteria, fungi, protozoa, worms, amongst other. In addition, molecular recognition of cancer, genetic disorders and species determination or sex determination of organisms has also achieved by LAMP. The LAMP reaction was found to be superior over the Polymerase Chain Reaction (PCR) in most cases with respect to detection limit, sensitivity, specificity and usefulness. The superior capability of LAMP relies on the application of primer sets consisting of four to six designated primers that recognize certain regions of the target nucleic acid sequence and on the incorporation of Bst DNA polymerase capable of splicing DNA strands. We can expect that research on and application of the LAMP method will take a course that is similar to that of the PCR method during the last decades, which means improvement of its already high sensitivity and specificity, improvement of its multiplexing capability, extension of its application fields to both highly specialized detection tasks and fields of economic interest and further cost reduction. This presentation will offer a valuable guide to the development of LAMP in molecular detection and determination of target sequences and will present examples with bright field applications of the method from the detection of pathogens to clinical applications for the diagnosis of cancer and other disorders according to current stage of this well-accepted methodology by the scientific community during the last decade.

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
Novel Drug Targeting Leukemia Cells Enters Clinical Trial
Phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for CLL patients.
Genetic Testing for Prostate Cancer
Genetic testing can identify men at six-fold increased risk of prostate cancer.
Redefining High Risk Patients With Stage II Colon Cancer
microRNA-21 identified as an independent prognostic biomarker.
Leukemia Subtype Becomes More Common With Age
Genomic Analysis of 1,725 patients reveals the prevalence of Ph-like ALL increases with age.
Ovarian Cancer Oncogene Found in "Junk DNA"
The study is published online in this week in Cancer Cell.
New Genetic Target for a Different Kind of Cancer Drug
Upstream of the proteins that cancer cells use to proliferate sits RBM4, a gene-splicing protein that is drastically reduced in human lung and breast cancer cells.
Combination microRNA Therapy Suppresses Non-Small-Cell Lung Cancer
Findings offer a promising therapeutic avenue for NSCLC.
Breakthrough Melanoma Treatment, Keytruda, Developed
New immunotherapy launched in the US for treatment of adults with advanced melanoma, developed using antibody humanization expertise at UK’s MRC Technology.
New Gene Mutations for Wilms Tumor
UT Southwestern researchers identified the mutated genes by sequencing the DNA of 44 tumors.
New Sequence of Naked Mole Rat Genome Facilitates Cancer Resistance Research
Director of Science at The Genome Analysis Centre (TGAC) Federica Di Palma co-authors new genetic study on the naked mole rat’s resistance to cancer, identifying key genomic variations that may have contributed to the evolution of this extraordinary species.
Scroll Up
Scroll Down
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv